definiens: or means all activities rel ating to obtaining Regulatory Approval of Licensed Products within theField and Territory, including, but not limited to, preclinical testing, toxicology, formulation, manu facturing processdevelopment, quality assurance and quality control, pharmacokinetics, clinical studies, Phase IV, deve lopment of kits and / ordevelopment of indications, applications and/or for mulations to the extent formulation development is limited to optimizationof the Licensed Product formulation such as formula tion modifications to reduce specific adverse event s, to reduce volume ofLicensed Product per injection and to reduce the to tal number of injections by for example increasing the concentration of HAor viscosity of HA solution ; provided that shall also mean any developments, inventions, processes, methods orworks of authorship which are created, developed, i nvented or reduced to practice in connection with p erforming the foregoingdescribed activities